Emma S. James

638 total citations
13 papers, 285 citations indexed

About

Emma S. James is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Emma S. James has authored 13 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Genetics. Recurrent topics in Emma S. James's work include Genetics and Neurodevelopmental Disorders (4 papers), Lysosomal Storage Disorders Research (4 papers) and Muscle Physiology and Disorders (3 papers). Emma S. James is often cited by papers focused on Genetics and Neurodevelopmental Disorders (4 papers), Lysosomal Storage Disorders Research (4 papers) and Muscle Physiology and Disorders (3 papers). Emma S. James collaborates with scholars based in United States, United Kingdom and Germany. Emma S. James's co-authors include Suyash Prasad, Benedikt Schoser, Digant Gupta, Deborah A. Bilder, Salvador Rico, Alan H. Beggs, Joseph Sullivan, David Dimmock, Maria Candida Vila and Simon Jones and has published in prestigious journals such as Journal of Neuropathology & Experimental Neurology, Archives of Disease in Childhood and Muscle & Nerve.

In The Last Decade

Emma S. James

13 papers receiving 279 citations

Peers

Emma S. James
Maya Chopra United States
Emily C. Lisi United States
Natasha Shur United States
M. Kujawa Poland
J. I. Manson Australia
Maya Chopra United States
Emma S. James
Citations per year, relative to Emma S. James Emma S. James (= 1×) peers Maya Chopra

Countries citing papers authored by Emma S. James

Since Specialization
Citations

This map shows the geographic impact of Emma S. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma S. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma S. James more than expected).

Fields of papers citing papers by Emma S. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma S. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma S. James. The network helps show where Emma S. James may publish in the future.

Co-authorship network of co-authors of Emma S. James

This figure shows the co-authorship network connecting the top 25 collaborators of Emma S. James. A scholar is included among the top collaborators of Emma S. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma S. James. Emma S. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kimberly, Laura L., et al.. (2023). The Lived Experience of Pediatric Gene Therapy: A Scoping Review. Human Gene Therapy. 34(23-24). 1180–1189. 6 indexed citations
2.
Sullivan, Joseph, Alison Deighton, Maria Candida Vila, et al.. (2022). The clinical, economic, and humanistic burden of Dravet syndrome – A systematic literature review. Epilepsy & Behavior. 130. 108661–108661. 43 indexed citations
3.
Juandó‐Prats, Clara, Emma S. James, Deborah A. Bilder, et al.. (2021). DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research. Epilepsy & Behavior. 122. 108198–108198. 25 indexed citations
4.
Duong, Tina, Gale Harding, Sally Mannix, et al.. (2020). Use of the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance. Journal of Neuromuscular Diseases. 8(1). 63–77. 7 indexed citations
5.
Mavilio, Fulvio, Justine J. Cunningham, Garrett C. Heffner, et al.. (2020). Pre-clinical safety and efficacy findings of AT845, a novel gene replacement therapy for Pompe disease targeting skeletal muscle and heart. Molecular Genetics and Metabolism. 129(2). S106–S106. 1 indexed citations
6.
Graham, Robert J., Francesco Muntoni, Imelda Hughes, et al.. (2019). Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis. Archives of Disease in Childhood. 105(4). 332–338. 25 indexed citations
7.
Schoser, Benedikt, Andreas Hahn, Emma S. James, et al.. (2019). A Systematic Review of the Health Economics of Pompe Disease. PharmacoEconomics - Open. 3(4). 479–493. 12 indexed citations
8.
Dhawan, Anil, Michael W. Lawlor, George Mazariegos, et al.. (2019). Disease burden of Crigler–Najjar syndrome: Systematic review and future perspectives. Journal of Gastroenterology and Hepatology. 35(4). 530–543. 27 indexed citations
9.
Schoser, Benedikt, Deborah A. Bilder, David Dimmock, et al.. (2017). The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurology. 17(1). 202–202. 43 indexed citations
10.
Beggs, Alan H., B. Byrne, Tmirah Haselkorn, et al.. (2017). A multicenter, retrospective medical record review of patients with X-Linked Myotubular myopathy (XLMTM): the RECENSUS study. Neuromuscular Disorders. 27. S172–S172. 1 indexed citations
11.
Beggs, Alan H., Barry J. Byrne, Tmirah Haselkorn, et al.. (2017). A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study. Muscle & Nerve. 57(4). 550–560. 39 indexed citations
12.
Lawlor, Michael W., Alan H. Beggs, Ana Buj‐Bello, et al.. (2016). Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. Journal of Neuropathology & Experimental Neurology. 75(2). 102–110. 38 indexed citations
13.
Jones, Simon, Emma S. James, & Suyash Prasad. (2010). Disease Registries and Outcomes Research in Children. Pediatric Drugs. 13(1). 33–47. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026